Filter
429
Filtered Results: 429
Text search:
HIVPA
Featured
Recommendations
22
New Publications
86
Language
Document type
No document type
225
Studies & Reports
76
Guidelines
60
Manuals
25
Strategic & Response Plan
18
Fact sheets
12
Training Material
5
Situation Updates
5
Brochures
1
Resource Platforms
1
Infographics
1
Countries / Regions
Global
25
Latin America and the Carribbean
23
Haiti
15
Kenya
13
Malawi
8
Ethiopia
8
Zambia
8
India
8
Indonesia
7
Colombia
6
Mozambique
6
Venezuela
6
USA
5
Congo, Democratic Republic of
5
South Africa
5
Uganda
5
Nigeria
4
Tanzania
4
Western and Central Europe
4
Liberia
4
Rwanda
3
Senegal
3
Guinea
3
Africa
3
Germany
3
Bangladesh
3
Brazil
3
Russia
3
Nepal
2
El Salvador
2
Syria
2
Peru
2
Philippines
2
Cambodia
2
Argentina
2
Namibia
2
Sudan
2
Myanmar / Burma
2
Thailand
1
Mexico
1
Ukraine
1
Ghana
1
Sierra Leone
1
Iran
1
Albania
1
Burkina Faso
1
Morocco
1
Jordan
1
Saudi Arabia
1
South–East Asia Region
1
Western Pacific Region
1
Paraguay
1
North America
1
Uruguay
1
Turkmenistan
1
Tunisia
1
Spain
1
East and Southern Africa
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Lebanon
1
Papua New Guinea
1
Nicaragua
1
Sri Lanka
1
Greece
1
Georgia
1
Honduras
1
Angola
1
South Sudan
1
Iraq
1
Somalia
1
Solomon Islands
1
Pakistan
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
127
Clinical Guidelines
38
Public Health
28
Capacity Building
14
Women & Child Health
12
Key Resources
11
Pharmacy & Technologies
5
Toolboxes
HIV
64
Mental Health
51
TB
38
COVID-19
25
NCDs
18
NTDs
15
Caregiver
11
Refugee
10
Cholera
10
Disability
9
Planetary Health
9
AMR
9
Rapid Response
8
Natural Hazards
7
Ebola
7
Global Health Education
7
Polio
5
Conflict
4
Social Ethics
3
Pharmacy
3
Health Financing Toolbox
2
Zika
2
The Faster We Go, the Health We'll Be.
The report outlines five climate solutions that research shows will deliver immediate, often localized, health and equity benefits. Our focus is on the solutions that proactively advance both health and health equity, recognizing that some of us face greater h...
To test for ethnic discrimination in access to outpatient health care services, we carry out
an email-correspondence study in Germany. We approach 3,224 physician offices in the 79
largest cities in Germany with fictitious appointment requests and randomized patients’
characteristics. We find t...
El Salvador's response to tuberculosis control: A sustainability analysis
La presente guía tiene además como objetivo, ser un respaldo y no una camisa de fuerza para los médicos, pues pretendemos con ella proveer evidencia sólida respecto a los riesgos, beneficios o consecuencias que puede generar la toma de una decisión en pacientes con tuberculosis. Como lo propone...
Tuberculosis continues to represent a severe public health problem in the Region of the Americas, even more so in the case of indigenous peoples, whose TB incidence is much higher than that of the general population. To achieve tuberculosis control in these communities, it is necessary to respond t...
Glob Heart . 2020 Oct 13;15(1):69. doi: 10.5334/gh.891.
Multiple countries are reporting severe acute cases of hepatitis of unknown aetiology in children, in several
regions of the world. WHO has developed this clinical case report form (CRF) to support and facilitate reporting
of anonymized, patient-level data of acute hepatitis of unknown aetiology.
The pandemic has emphasized the high risk of avoidable harm to patients, health workers, and the general public, and has identified a range of safety gaps across all core components of health systems at all levels.
The rapid review ‘Implications of the COVID-19 pandemic for patient safety’ ex...
Las guías para la prevención de Infecciones del Sitio Quirúrgico (ISQ) resumen las medidas basadas en la evidencia que han demostrado disminuir su incidencia y mejorar la calidad asistencial de los pacientes sometidos a cirugía. La última revisión local fue realizada en el año 2009, en el mar...
Ces orientations relatives à la prescription par les infirmières sont destinées à aider les infirmières, les équipes, les associations, les organisations, les enseignants, les organismes de réglementation et les gouvernements du monde entier. Les nations et les régions peuvent évaluer les b...
Not long ago, on the occasion of the 100th anniversary of the discovery of Chagas disease, several campaigns denounced the scant progress has been made in diffrent spheres- medical, scientific and politcal- but major challanges still remain. This is an appropriate time to celebrate what has been ach...
This document compiles the recommendations made by the World Health Organization (WHO) and the Pan American Health Organization (PAHO) to help professionals in charge of vector control programs in Latin America and the Caribbean at the national, subnational, and local level update their knowledge in...
El presente documento reúne un conjunto de recomendaciones formuladas por la Organización Mundial de la Salud (OMS) y la Organización Panamericana de la Salud (OPS) para ayudar, a los profesionales encargados de los programas de control de vectores de Latinoamérica y el Caribe a nivel nacional, ...
Este documento reúne um conjunto de recomendações formuladas pela OMS e pela OPAS para ajudar os profissionais responsáveis pelos programas de controle de vetores nas Américas em nível nacional, subnacional e local a se atualizarem e tomarem decisões baseadas em evidências sobre as medidas d...
Two adjectives raise an issue for communicators working on Chagas disease (CD): “invisible and silent”. Two adjectives that can be ascribed to other neglected tropical diseases (NTD), but which are part of the essence of CD. Bringing CD out of its situation of neglect and oblivion is a mission e...
Epidemiology
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or...
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or drink.1-4 The...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
